Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 20;15(2):96777.
doi: 10.5662/wjm.v15.i2.96777.

Prognostic factors for acute central retinal artery occlusion treated with hyperbaric oxygen: The Hong Kong study report number five

Affiliations

Prognostic factors for acute central retinal artery occlusion treated with hyperbaric oxygen: The Hong Kong study report number five

Sunny Chi Lik Au et al. World J Methodol. .

Abstract

Background: Central retinal artery occlusion (CRAO) is a potentially blinding disease, and hyperbaric oxygen therapy (HBOT) is becoming increasingly popular with the support of scientific evidence. Despite the presence of various acute management measures, there is no clear evidence on the gold standard treatment for CRAO.

Aim: To identify factors and imaging parameters associated with good visual outcome, which guide ophthalmologists in the triage of CRAO patients for HBOT.

Methods: Patients who suffered from CRAO and had a symptom onset ≤ 6 h were recruited for a course of HBOT in a tertiary hospital after failing bedside treatment. Patient demographics, onset time, CRAO eye parameters, and past medical history were prospectively collected. Visual outcomes after HBOT were also analyzed.

Results: A total of 26 patients were included; the female-to-male ratio was 1:1.6, and the mean age was 67.5 years ± 13.3 years (range 44-89 years). The mean duration of follow-up and mean visual acuity (VA) improvement were 10.0 mo ± 5.3 mo and 0.48 logarithm of minimal angle of resolution (logMAR) ± 0.57 logMAR (approximately 9 letters in ETDRS) (P = 0.0001, Z = -3.67), respectively. The 1 mm zone of central macular thickness (CMT) on optical coherence tomography was not associated with VA changes (P = 0.119); however, the 1-to-3 mm circular rim of CMT was fairly associated (P = 0.02, Spearman's coefficient = 0.45). Complete retinal perfusion time during fundus fluorescein angiography (FFA) was moderately associated (P = 0.01, Spearman's coefficient = 0.58) with visual outcome.

Conclusion: A thinner 1-to-3 mm circular rim of CMT, but not the central 1 mm zone, is associated with better visual outcome. A shorter perfusion delay on FFA is also associated with better visual outcome.

Keywords: Central retinal artery occlusion; Fundus fluorescein angiography; Hyperbaric oxygen therapy; Optical coherence tomography; Stroke.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: Neither authors received fees for serving as a speaker. Neither authors received research funding. Both authors are employees of Hong Kong East Cluster Ophthalmic Service Unit of Hong Kong Hospital Authority.

Figures

Figure 1
Figure 1
An optical coherence tomography scan report. A: An optical coherence tomography scan report example with machine generated thickness map for a left eye suffering from acute central retinal artery occlusion; B: The encircled central 1 mm zone thickness data was extracted from the printout; C: The highlighted area indicates the central 1-to-3 mm zone on the thickness map.
Figure 2
Figure 2
Flowchart of patient recruitment.

Similar articles

References

    1. Flaxel CJ, Adelman RA, Bailey ST, Fawzi A, Lim JI, Vemulakonda GA, Ying GS. Retinal and Ophthalmic Artery Occlusions Preferred Practice Pattern®. Ophthalmology. 2020;127:P259–P287. - PubMed
    1. Gaál V, Kölkedi Z, Szapáry L, Csutak A, Szalai E. [Acute central retinal artery occlusion: Proposed therapeutic approach for ocular stroke] Orv Hetil. 2021;162:1871–1875. - PubMed
    1. Varma DD, Cugati S, Lee AW, Chen CS. A review of central retinal artery occlusion: clinical presentation and management. Eye (Lond) 2013;27:688–697. - PMC - PubMed
    1. Cugati S, Varma DD, Chen CS, Lee AW. Treatment options for central retinal artery occlusion. Curr Treat Options Neurol. 2013;15:63–77. - PMC - PubMed
    1. Dumitrascu OM, Newman NJ, Biousse V. Thrombolysis for Central Retinal Artery Occlusion in 2020: Time Is Vision! J Neuroophthalmol. 2020;40:333–345. - PMC - PubMed

LinkOut - more resources